- Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists
-
Shang P, Baker M, Banks S, Hong SI, Choi DS
- KMID: 2547815
- J Mov Disord.
- 2021 Sep;14(3):193-203.
- doi: 10.14802/jmd.21035
Parkinson’s disease (PD) is a severe neurodegenerative disease characterized by classic motor features associated with the loss of dopaminergic neurons and appearance of Lewy bodies in the substantia nigra. Due... -
- CITED
-
- Close
- SHARE
-
- Close
